Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma
about
The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancerEarly Recurrence and Omission of Adjuvant Therapy after Pancreaticoduodenectomy Argue against a Surgery-First Approach.Analysis on survival and prognostic factors in patients with resectable pancreatic adenocarcinoma.
P2860
Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma
@ast
Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma
@en
Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma
@nl
type
label
Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma
@ast
Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma
@en
Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma
@nl
prefLabel
Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma
@ast
Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma
@en
Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma
@nl
P2093
P2860
P3181
P1476
Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma
@en
P2093
Andrea Wang-Gillam
Jeffrey R Olsen
Lingling Du
Marianna B Ruzinova
Melissa DeFoe
P2860
P304
P3181
P356
10.1016/J.HOC.2015.04.011
P407
P577
2015-08-01T00:00:00Z